MedTrace Logo

Intestinal Microbiota of Breast Cancer Patients Undergoing Chemotherapy

NCT04138979 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2019-10-25

No results posted yet for this study

Summary

To date, few studies have addressed the link between gut microbiota and breast cancer chemotherapy, and previous studies have only provided a link between the gut and breast cancer.

Conditions

  • Microbiota

Interventions

DRUG

cyclophosphamide

First use of chemotherapy after breast cancer

Sponsors & Collaborators

  • First Affiliated Hospital of Harbin Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-12
Primary Completion
2020-10-15
Completion
2020-10-15
FDA Drug
Yes

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04138979 on ClinicalTrials.gov